ICML 2025
Interviews from International Conference on Malignant Lymphoma
ICML 2025
Interviews from International Conference on Malignant Lymphoma
The 18th International Conference on Malignant Lymphomas was held in Lugano from June 17 to 21. The event brought together over 5,000 experts from numerous countries, highlighting emerging trends such as the use of ctDNA to guide therapies and advances in second-generation CAR-T. There was also a strong focus on tumor profiling and personalized medicine, with new predictive tools for Hodgkin's and non-Hodgkin's lymphomas.
The 18th International Conference on Malignant Lymphomas was held in Lugano from June 17 to 21. The event brought together over 5,000 experts from numerous countries, highlighting emerging trends such as the use of ctDNA to guide therapies and advances in second-generation CAR-T. There was also a strong focus on tumor profiling and personalized medicine, with new predictive tools for Hodgkin's and non-Hodgkin's lymphomas.
Improving Outcomes for Lymphoma Patients: Why We Believe It's Possible
en
Prof. Bruce D. Cheson
Diffuse large cell lymphoma, subgroup classification and targeted therapies
en
Prof. Riccardo Dalla Favera
From monoclonal B-cell lymphocytosis to chronic lymphocytic leukemia (CLL): progression and evolution
it
Prof. Paolo Ghia
Lymphomas: reliable diagnosis only with correctly performed techniques
en
Dr. Elaine S. Jaffe
Lymphoma research as a model for other cancers
en
Dr. Margaret Foti
Towards personalized treatment in DLBCL: preliminary results from SAKK 38/19
en
Anastasios Stathis
Biologics and precision medicine in mantle cell lymphoma
it
Prof. Simone Ferrero